Peptides for SARS-CoV-19 Research

GenScript provides a full spectrum of high-quality peptide services ranging from Custom Peptide Synthesis (research and cGMP grade) to high-throughput to high-throughput Peptide Library and Peptide Array services. With access to the state-of-the-art equipment and experienced chemists using the latest technologies, we have delivered over 600,000 custom peptides to more than 10,000 scientists worldwide. 

To meet the increasing demand for COVID-19 research, GenScript has developed a series of SARS-CoV-2 Peptide and Peptide Libraries based on GenScript's rich experience in peptide design and synthesis. 

You can find the peptides as below, and more peptide services here.

Peptide

Description

MCP_0001569

(Biotin - Ahx) - SARS - CoV - 2 Spike RBM (receptor binding motif)

This peptide sequence has residues 438-458 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the N-terminus.

MCP_0001570

SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335

This peptide sequence represents residues 319-335 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

MCP_0001571

SARS - CoV - 2 Spike RBD (receptor binding domain), 319 - 335 - Lys(Biotin - Ahx)

This peptide sequence represents residues 319-335 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001572

SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347

This peptide sequence represents residues 336-347 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

MCP_0001573

SARS - CoV - 2 Spike RBD (receptor binding domain), 336 - 347 - Lys(Biotin - Ahx)

This peptide sequence represents residues 336-347 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001574

SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357

This peptide sequence represents residues 348-357 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

MCP_0001575

SARS - CoV - 2 Spike RBD (receptor binding domain), 348 - 357 - Lys(Biotin - Ahx)

This peptide sequence represents residues 348-357 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001576

SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365

This peptide sequence represents residues 352-365 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

MCP_0001577

SARS - CoV - 2 Spike RBD (receptor binding domain), 352 - 365 - Lys(Biotin - Ahx)

This peptide sequence represents residues 352-365 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001578

SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394

This peptide sequence represents residues 371-394 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

MCP_0001579

SARS - CoV - 2 Spike RBD (receptor binding domain), 371 - 394 - Lys(Biotin - Ahx)

This peptide sequence represents residues 371-394 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001580

SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430

This peptide sequence represents residues 395-430 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

MCP_0001581

SARS - CoV - 2 Spike RBD (receptor binding domain), 395 - 430 - Lys(Biotin - Ahx)

This peptide sequence represents residues 395-430 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001582

SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520

This peptide sequence represents residues 513-520 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2

MCP_0001583

SARS - CoV - 2 Spike RBD (receptor binding domain), 513 - 520 - Lys(Biotin - Ahx)

This peptide sequence represents residues 513-520 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001584

SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541

This peptide sequence represents residues 523-541 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2.

MCP_0001585

SARS - CoV - 2 Spike RBD (receptor binding domain), 523 - 541 - Lys(Biotin - Ahx)

This peptide sequence represents residues 523-541 of the RBD (receptor binding domain) identified from the RefSeq (YP_009724390.1) from the spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001586

SARS - CoV - 2 Spike RBM (receptor binding motif), 438 - 458

This peptide sequence has residues 438-458 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.

MCP_0001587

SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473

This peptide sequence has residues 450-473 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.

MCP_0001588

SARS - CoV - 2 Spike RBM (receptor binding motif), 450 - 473 - Lys(Biotin - Ahx)

This peptide sequence has residues 450-473 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001589

SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496

This peptide sequence has residues 480-496 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.

MCP_0001590

SARS - CoV - 2 Spike RBM (receptor binding motif), 480 - 496 - Lys(Biotin - Ahx)

This peptide sequence has residues 480-496 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0001591

SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509

This peptide sequence has residues 500-509 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2.

MCP_0001592

SARS - CoV - 2 Spike RBM (receptor binding motif), 500 - 509 - Lys(Biotin - Ahx)

This peptide sequence has residues 500-509 obtained from the RBM (receptor binding motif: 437-508) identified within the RBD from the RefSeq (YP_009724390.1) of spike protein of SARS-CoV-2. The sequence is labeled with Biotin-Ahx at the C-terminus.

MCP_0000053

Angiotensin I Converting Enzyme 2, (ACE - 2) Substrate

An ACE-2 (Angiotensin I-converting enzyme 2) fluorescent substrate. Complete hydrolysis of 0.04 mM results in a 300-fold fluorescence increase over background. Max Abs/Em=325/393 nm upon cleavage of substrate.

MCP_0000359

DX 600, ACE2 Inhibitor

A potent inhibitor specific for ACE2. It has a Ki of 2.8 nM.


Reply

About Us · User Accounts and Benefits · Privacy Policy · Management Center · FAQs
© 2020 MolecularCloud